AG
ANIP icon

Algert Global’s ANI Pharmaceuticals ANIP Stock Holding History

Algert Global’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,910
Closed -$2.83M – 1152
2025
Q4 		$2.83M Buy
35,910
+30,680
+587% +$2.66M 0.04% 616
2025
Q3 		$479K Buy
+5,230
New +$426K 0.01% 930
2024
Q3 		– Sell
-12,951
Closed -$825K – 1187
2024
Q2 		$825K Sell
12,951
-23,629
-65% -$1.53M 0.03% 733
2024
Q1 		$2.53M Buy
36,580
+22,180
+154% +$1.34M 0.1% 336
2023
Q4 		$794K Buy
+14,400
New +$793K 0.03% 683
2023
Q3 		– Sell
-6,661
Closed -$359K – 1099
2023
Q2 		$359K Buy
+6,661
New +$295K 0.02% 876
2019
Q1 		– Sell
-4,961
Closed -$223K – 306
2018
Q4 		$223K Sell
4,961
-22,334
-82% -$1.17M 0.06% 324
2018
Q3 		$1.54M Sell
27,295
-2,739
-9% -$168K 0.33% 112
2018
Q2 		$2.01M Sell
30,034
-4,692
-14% -$293K 0.42% 93
2018
Q1 		$2.02M Buy
34,726
+4,221
+14% +$268K 0.39% 102
2017
Q4 		$1.97M Buy
+30,505
New +$1.9M 0.46% 96

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Algert Global's ANIP Position: Q1 2026 in Review

Algert Global sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 35,910 shares — an estimated $2.83M sold.

Algert Global first reported a position in ANIP in Q4 2017 and held it in 11 quarters. The position peaked at $2.83M in Q4 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Algert Global reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 35,910 ANI Pharmaceuticals shares in Q1 2026, an estimated $2.83M.
  • Algert Global first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 11 quarters.
  • Algert Global's ANI Pharmaceuticals position peaked at $2.83M in Q4 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.